Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Phase III study to compare the safety and efficacy of intraocular implants containing
Travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5%
(Timolol) in reducing elevated intraocular pressure in subjects with open angle glaucoma
(OAG) or ocular hypertension (OHT)